CryoLife (Germany) Performance
| CYL Stock | EUR 27.20 0.20 0.74% |
On a scale of 0 to 100, CryoLife holds a performance score of 9. The firm shows a Beta (market volatility) of 0.6, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CryoLife's returns are expected to increase less than the market. However, during the bear market, the loss of holding CryoLife is expected to be smaller as well. Please check CryoLife's maximum drawdown, semi variance, daily balance of power, as well as the relationship between the potential upside and skewness , to make a quick decision on whether CryoLife's price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CryoLife are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, CryoLife reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 55 M |
CryoLife |
CryoLife Relative Risk vs. Return Landscape
If you would invest 2,410 in CryoLife on August 30, 2024 and sell it today you would earn a total of 310.00 from holding CryoLife or generate 12.86% return on investment over 90 days. CryoLife is currently producing 0.2033% returns and takes up 1.6954% volatility of returns over 90 trading days. Put another way, 15% of traded stocks are less volatile than CryoLife, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
CryoLife Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CryoLife's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CryoLife, and traders can use it to determine the average amount a CryoLife's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1199
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CYL | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.7 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average CryoLife is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CryoLife by adding it to a well-diversified portfolio.
CryoLife Fundamentals Growth
CryoLife Stock prices reflect investors' perceptions of the future prospects and financial health of CryoLife, and CryoLife fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CryoLife Stock performance.
| Return On Equity | -0.0656 | |||
| Return On Asset | 0.0122 | |||
| Profit Margin | (0.06) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 796.78 M | |||
| Shares Outstanding | 40.56 M | |||
| Price To Earning | 303.28 X | |||
| Price To Book | 2.05 X | |||
| Price To Sales | 1.53 X | |||
| Revenue | 313.79 M | |||
| EBITDA | 25.68 M | |||
| Cash And Equivalents | 40.26 M | |||
| Cash Per Share | 1.08 X | |||
| Total Debt | 306.5 M | |||
| Debt To Equity | 98.30 % | |||
| Book Value Per Share | 7.05 X | |||
| Cash Flow From Operations | (5.15 M) | |||
| Earnings Per Share | (0.44) X | |||
| Total Asset | 762.8 M | |||
About CryoLife Performance
By analyzing CryoLife's fundamental ratios, stakeholders can gain valuable insights into CryoLife's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CryoLife has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CryoLife has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people.Things to note about CryoLife performance evaluation
Checking the ongoing alerts about CryoLife for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CryoLife help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CryoLife has high likelihood to experience some financial distress in the next 2 years | |
| CryoLife has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 313.79 M. Net Loss for the year was (19.19 M) with profit before overhead, payroll, taxes, and interest of 202.52 M. | |
| CryoLife has accumulated about 40.26 M in cash with (5.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.08. | |
| Over 87.0% of the company shares are held by institutions such as insurance companies |
- Analyzing CryoLife's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CryoLife's stock is overvalued or undervalued compared to its peers.
- Examining CryoLife's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CryoLife's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CryoLife's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CryoLife's stock. These opinions can provide insight into CryoLife's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CryoLife Stock analysis
When running CryoLife's price analysis, check to measure CryoLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CryoLife is operating at the current time. Most of CryoLife's value examination focuses on studying past and present price action to predict the probability of CryoLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CryoLife's price. Additionally, you may evaluate how the addition of CryoLife to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |